Clinical trial

Anti-viral Action Against Type 1 Diabetes Autoimmunity

NCT06452654

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-05-08

PhasePHASE4

Study timeline

Study start (actual)2024-05-08Date precision: day

Registry last updated2025-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

Comirnaty Injectable ProductDRUG

Sodium Chloride 0.9% InjDRUG

Sponsors & collaborators

Technical University of Munichlead sponsor

Helmholtz Zentrum Münchencollaborator

University Hospital Carl Gustav Caruscollaborator

Kinderkrankenhaus auf der Bultcollaborator

Skane University Hospitalcollaborator

Universitaire Ziekenhuizen KU Leuvencollaborator

Newcastle-upon-Tyne Hospitals NHS Trustcollaborator

Cambridge University Hospitals NHS Foundation Trustcollaborator

Birmingham Women's and Children's NHS Foundation Trustcollaborator

Mapped research locations

ViennaAustria1 LeuvenBelgium1 BirminghamUnited Kingdom1 CambridgeUnited Kingdom1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06452654 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.